2022 研究成果

2022 研究成果

2022年

CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence
Serizawa K, Tanaka H, Ueda T, Fukui A, Kakutani H, Taniguchi T, Inoue H, Kumode T, Taniguchi Y, Rai S, et al. International Journal of Hematology. 2022. 115. 3. 336-349

 https://link.springer.com/article/10.1007/s12185-021-03261-0